Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence R Wilson

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Cell Science|May 18, 2016
Cdk-dependent phosphorylation regulates TRF1 recruitment to PML bodies and promotes C-circle production in ALT cellsFlorence R Wilson, Angus Ho, John R Walker, et al.
Breast Cancer Research and Treatment|July 29, 2017
Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancerFlorence R Wilson, Abhishek Varu, Debanjali Mitra, et al.
Current Medical Research and Opinion|February 8, 2019
Treatment sequence network meta-analysis in Crohn's disease: a methodological case studyAbhishek Varu, Florence R Wilson, Peter Dyrda, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 17, 2017
The Importance of Considering Differences in Study Design in Network Meta-analysis: An Application Using Anti-Tumor Necrosis Factor Drugs for Ulcerative ColitisChris Cameron, Emmanuel Ewara, Florence R Wilson, et al.
Nucleic Acids Research|September 3, 2013
Phosphorylated (pT371)TRF1 is recruited to sites of DNA damage to facilitate homologous recombination and checkpoint activationMegan McKerlie, John R Walker, Taylor R H Mitchell, et al.
Scientific Reports|November 15, 2016
TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodiesAngus Ho, Florence R Wilson, Stephanie L Peragine, et al.
Systematic Reviews|October 12, 2017
Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysisFlorence R Wilson, Megan E Coombes, Quinlan Wylie, et al.
Frontiers in Cardiovascular Medicine|February 5, 2025
A systematic literature review to evaluate the cardiac and cerebrovascular outcomes of patients with Fabry disease treated with agalsidase BetaGavin Y Oudit, Pronabesh DasMahapatra, Nicole Lyn, et al.
Journal of Comparative Effectiveness Research|April 20, 2023
Indirect treatment comparison of lurbinectedin versus other second-line treatments for small-cell lung cancerRaj Hanvesakul, Badri Rengarajan, Navit Naveh, et al.
European Urology Oncology|June 26, 2026
Adjusted Comparison of First-line Enfortumab Vedotin Plus Pembrolizumab Versus Platinum-based Chemotherapy ± Avelumab Maintenance for the Treatment of Locally Advanced/Metastatic Urothelial CarcinomaRyan Dillon, Robert Jones, Aude Fléchon, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Cell Science|May 18, 2016
Cdk-dependent phosphorylation regulates TRF1 recruitment to PML bodies and promotes C-circle production in ALT cellsFlorence R Wilson, Angus Ho, John R Walker, et al.
Breast Cancer Research and Treatment|July 29, 2017
Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancerFlorence R Wilson, Abhishek Varu, Debanjali Mitra, et al.
Current Medical Research and Opinion|February 8, 2019
Treatment sequence network meta-analysis in Crohn's disease: a methodological case studyAbhishek Varu, Florence R Wilson, Peter Dyrda, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 17, 2017
The Importance of Considering Differences in Study Design in Network Meta-analysis: An Application Using Anti-Tumor Necrosis Factor Drugs for Ulcerative ColitisChris Cameron, Emmanuel Ewara, Florence R Wilson, et al.
Nucleic Acids Research|September 3, 2013
Phosphorylated (pT371)TRF1 is recruited to sites of DNA damage to facilitate homologous recombination and checkpoint activationMegan McKerlie, John R Walker, Taylor R H Mitchell, et al.
Scientific Reports|November 15, 2016
TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodiesAngus Ho, Florence R Wilson, Stephanie L Peragine, et al.
Systematic Reviews|October 12, 2017
Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysisFlorence R Wilson, Megan E Coombes, Quinlan Wylie, et al.
Frontiers in Cardiovascular Medicine|February 5, 2025
A systematic literature review to evaluate the cardiac and cerebrovascular outcomes of patients with Fabry disease treated with agalsidase BetaGavin Y Oudit, Pronabesh DasMahapatra, Nicole Lyn, et al.
Journal of Comparative Effectiveness Research|April 20, 2023
Indirect treatment comparison of lurbinectedin versus other second-line treatments for small-cell lung cancerRaj Hanvesakul, Badri Rengarajan, Navit Naveh, et al.
European Urology Oncology|June 26, 2026
Adjusted Comparison of First-line Enfortumab Vedotin Plus Pembrolizumab Versus Platinum-based Chemotherapy ± Avelumab Maintenance for the Treatment of Locally Advanced/Metastatic Urothelial CarcinomaRyan Dillon, Robert Jones, Aude Fléchon, et al.
Pageof 2